Mylan to Buy Sweden’s Meda for $9.9 Billion

15.02.2016 - On the rebound from its failed $27 billion hostile bid for Perrigo, Netherlands-domiciled, US-managed drugmaker Mylan has announced it will acquire Sweden’s Meda for 83.6 billion...